FUMAPHARM
FUMAPHARM
Industry:
Biotechnology Pharmaceutical
Founded:
1983-01-01
Address:
Luzern, Luzern, Switzerland
Country:
Switzerland
Website Url:
http://www.fumapharm.ch
Status:
Closed
Technology used in webpage:
Amazon CSC Global DNS
Similar Organizations
Citron Pharma
Citron Pharma is a privately held pharmaceutical company.
NPK Biotest
NPK Biotest is a privately held pharmaceutical company.
Therabel Group
Therabel is a privately-owned pharmaceutical company,
Therawis
Therawis Pharma GmbH is a privately held, profitable oncology-specialized company.
Official Site Inspections
http://www.fumapharm.ch
- Host name: 203.27.227.220
- IP address: 203.27.227.220
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney
More informations about "Fumapharm"
Fumapharm - Crunchbase Company Profile & Funding
Fumapharm is located in Luzern, Luzern, Switzerland. Who are Fumapharm 's competitors? Alternatives and possible competitors to Fumapharm may include GPW Group , GP Pharm , …See details»
Fumapharm Company Profile 2024: Valuation, Investors
Fumapharm was founded in 1983. Where is Fumapharm headquartered? Fumapharm is headquartered in Luzern, Switzerland. What industry is Fumapharm in? Fumapharm’s primary …See details»
Fumapharm - Company Profile - Tracxn
Fumapharm develops therapeutics derived from fumaric acid esters for patients suffering from autoimmune diseases. It markets Fumaderm for the treatment of psoriasis. Fumaderm is a …See details»
Fumapharm AG - Ownership and Business Overview - Mergr
May 31, 2006 Fumapharm is a privately held pharmaceutical company headquartered in Lucerne, Switzerland. FUMADERM, an oral product containing fumaric acid esters, was …See details»
Fumapharm AG - Luzern, Switzerland - bionity.com
Jun 6, 2006 As of May 31, 2006, Fumapharm AG was acquired by Biogen Idec, Inc. Fumapharm AG, a pharmaceutical company, develops therapeutics. Its products include FUMADERM for …See details»
Fumapharm AG:Company Profile & Technical Research,Competitor …
Feb 18, 2023 Fumapharm AG is headquartered in Switzerland Luzern. Fumapharm AG was founded in 1983. Fumapharm AG has a total of 177 patentsSee details»
Fumapharm AG - VentureRadar
Fumapharm AG VentureRadar profile. Find out more about Fumapharm AG including the VentureRadar Innovation and Growth scores, Similar Companies and more. ... Richter-Helm …See details»
Fumapharm AG - Luzern, Schweiz - bionity.com
Jun 2, 2006 News. Wir bringen Sie jederzeit auf den neuesten Stand: Entdecken Sie aktuelle Branchen-News aus Biotechnologie, Pharma und Life Sciences. Von uns recherchiert, damit …See details»
Biogen International GmbH · Fumapharm AG · Landis
The address is Landis + Gyr-Strasse 3, Zug, CH-ZG, 6300, CH. Toggle navigation open corp data. Jurisdiction. ... Fumapharm AG. address: Landis + Gyr-Strasse 3, Zug, CH-ZG, 6300, …See details»
Fumapharm - Crunchbase
Fumapharm is a privately held pharmaceutical company. Start Free Trial . Chrome ExtensionSee details»
Fumapharm AG - BioCentury Company Profiles - BCIQ
Jan 13, 2014 Fumapharm AG - BioCentury Company Profiles for the biopharma industrySee details»
Fumapharm AG - Luzern, Suiza - bionity.com
El 31 de mayo de 2006, Fumapharm AG fue adquirida por Biogen Idec, Inc. Fumapharm AG, una empresa farmacéutica, desarrolla productos terapéuticos. ... fumapharm.ch +41413712046. …See details»
Fumapharm Services AG, Muri, Schweiz - North Data
Fumapharm Services AG, Muri, Schweiz, Schweizer Handelsregister CHE-109.572.705: Netzwerk, WirtschaftsinfosSee details»
Fumapharm Services AG :: Switzerland - OpenCorporates
Free and open company data on Switzerland company Fumapharm Services AG (company number 673753), Seetalstrasse, 5, Muri, 5630. Learn how to leverage transparent company …See details»
Fumapharm Ag Trademarks & Logos - US Patent and Trademark …
Fumapharm AG - Muri CH; Trademarks Patents. Patent Applications. Patent Application Date; USE OF FUMARIC ACID DERIVATIVES FOR TREATING CARDIAC INSUFFICIENCY, AND …See details»
Biogen Idec, Inc. (Massachusetts) To Acquire Fumapharm AG
May 31, 2006 In October 2003, Biogen Idec licensed certain exclusive worldwide rights to develop and market BG-12, oral fumarate derivative with an immunomodulatory mechanism of …See details»
Biogen Idec agrees to buy Swiss company Fumapharm
Jun 1, 2006 Biogen Idec and Fumapharm have been collaborating on a drug for multiple sclerosis and psoriasis, BG-12, since October 2003. This agent has already cleared one …See details»
Biogen Idec to acquire Fumapharm AG - bionity.com
Jun 6, 2006 Fumapharm AG, founded in Switzerland in 1983, develops therapeutics derived from fumaric acid esters for patients with high unmet medical need. The company has two …See details»
Biogen Idec to acquire Fumapharm AG | Drug Discovery News
LUCERNE, Switzerland—Biogen Idec and Fumapharm AG, a privately held pharmaceutical company, in late spring announced a definitive agreement whereby Fumapharm will be …See details»
Former Swiss shareholders of Fumapharm get USD761 million in …
Aug 5, 2012 Fumapharm was bought by Biogen Idec in 2006 for USD220 million. With the earn-out the former shareholders will get USD761 on top. Last week, Biogen Idec presented …See details»